Natick, MA - The US FDA has granted marketing clearance for the FilterWire EZ embolic-protection system for use in carotid stenting, the manufacturer, Boston Scientific, announced yesterday. The ...

A 73 year old diabetic and normotensive man presented with a history of chest pain with duration of 2 weeks. Dobutamine stress testing induced anterior wall motion abnormalities. He had undergone CABG ...

Use of embolic protection devices during saphenous vein graft (SVG) interventions is associated with an increase in procedural complications without corresponding improvements in clinical outcomes for ...

Natick-based Boston Scientific Corp. has been given the go-ahead from the U.S. Food and Drug Administration to market its FilterWire EX Embolic Protection System to treat saphenous vein graft (SVG) ...

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the ...

Please provide your email address to receive an email when new articles are posted on . How many randomized clinical trials of parachutes vs. no parachutes are there? The answer, of course, is none.

DUBLIN--(BUSINESS WIRE)--The "Global and Chinese Embolic protection systems Industry, 2018 Market Research Report" report has been added to ResearchAndMarkets.com's offering. This report provides key ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — In PROTECTED TAVR, the largest-ever randomized trial of transcatheter aortic valve replacement, ...